
A Small Molecule Drug Candidate for Alzheimer’s Treatment
During the 2025 AD/PD International Conference on Alzheimer‘s and Parkinson‘s Diseases and Related Neurological Disorders in Vienna, Galimedix Therapeutics presented pre-clinical data on an oral drug, GAL-201. The data highlight the small molecule’s …